Has a history of (noninfectious) pneumonitis that required steroids or has current pneumonitis.
Has evidence of active, noninfectious pneumonitis that requires treatment with steroids
Has a history of (noninfectious) pneumonitis that required steroids or has current pneumonitis
History of (noninfectious) pneumonitis that require steroids or current pneumonitis
Has evidence of active, noninfectious pneumonitis that required treatment with steroids
History of (noninfectious) pneumonitis that required systemic steroids or current pneumonitis/interstitial lung disease.
Patients who have evidence of active, noninfectious pneumonitis or have a history of severe pneumonitis that required treatment with steroids are not eligible for this study
Patients with a history of noninfectious pneumonitis will be excluded during the dose-escalation phase of the trial
Has a history of (noninfectious) pneumonitis that required steroids or has current pneumonitis
Has evidence of noninfectious pneumonitis that required steroids or current pneumonitis.
History of (noninfectious) pneumonitis that required steroids or current pneumonitis.
Patients who have evidence of active, noninfectious pneumonitis or have a history of severe pneumonitis that required treatment with steroids are not eligible for this study; (Note: replacement physiologic dose of steroids [prednisone  mg daily or equivalent] are allowed)
History of (noninfectious) pneumonitis that required steroids or current pneumonitis
History of noninfectious pneumonitis
History or evidence of active, noninfectious pneumonitis that required treatment with steroids
EXCLUSION CRITERIA FOR CROSSOVER THERAPY: History or evidence of active, noninfectious pneumonitis that required treatment with steroids